title: Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma?
authors.forename: Gonzalo
authors.initials: G
authors.lastname: Sapisochin
authors.forename: Francis Y
authors.initials: FY
authors.lastname: Yao
authors.forename: John P
authors.initials: JP
authors.lastname: Roberts
mesh_terms: D000206:Actuarial Analysis; D006528:Carcinoma, Hepatocellular / Q000276:immunology* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D018572:Disease-Free Survival; D005500:Follow-Up Studies; D006801:Humans; D007958:Leukocyte Count; D008113:Liver Neoplasms / Q000276:immunology* / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D018655:Lymphocyte Count; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000276:immunology* / Q000401:mortality; D009367:Neoplasm Staging; D009504:Neutrophils / Q000276:immunology*; D011237:Predictive Value of Tests; D011379:Prognosis; D012189:Retrospective Studies